Novel reaction to new cystic fibrosis medication Trikafta

Abstract

Abstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.

Keywords

• cystic fibrosis
• drug rash
• Trikafta
• urticaria
• urticaria multiforme